跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
3-a
首页
药物
3-a
3-a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
申请人: SAVILE CHRISTOPHER
优先权: 2009
US
Combretastatin A-3 prodrug
申请人: UNIV ARIZONA
优先权: 2003
US
2 件公开
MEDICINE COMPRISING A TOLL LIKE RECEPTOR 3 AGONIST AND A LAG-3 PROTEIN
申请人: CYTLIMIC INC
优先权: 2015
EP
US
3 件公开
3'-N-Substituted-3-O-Substituted Erythronolide a Derivatives
申请人: DAS BISWAJIT
优先权: 2003
US
Transgenic expression from a SOCS-3 promoter in vertebrate cells
申请人: CEDARS SINAI MEDICAL CENTER
优先权: 2002
US
6 件公开
A PHARMACEUTICAL COMPOSITION COMPRISING A FUMARIC ACID SALT OF (+)-3-(2,3-DIFLUOROPHENYL)-3-METHOXYPYRROLIDINE
申请人: INTEGRATIVE RES LABORATORIES SWEDEN AB
优先权: 2023
EP
WO
2 件公开
Application of 3'-hydroxyl chickpeanin A and pharmaceutical composition containing 3'-hydroxyl chickpeanin A
申请人: UNIV TIANJIN TRADITIONAL CHINESE MEDICINE
优先权: 2016
CN
METHOD OF LABELLING A BIOLOGICALLY ACTIVE MOLECULE WITH A 5-FLUORO-5-DEOXYPENTOSE OR A 3-FLUORO-3-DEOXYPENTOSE
申请人: UNIV ST ANDREWS
优先权: 2011
EP
US
WO
4 件公开
药物
反馈